Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

Casadevall, Arturo

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

Published Date:

Aug 2002

Source:

Emerg Infect Dis. 8(8):833-841.

[PDF - 288.17 KB]

Details:

Personal Authors:

Casadevall, Arturo

Keywords:

[+]

Description:

The potential threat of biological warfare with a specific agent is proportional to the susceptibility of the population to that agent. Preventing disease after exposure to a biological agent is partially a function of the immunity of the exposed individual. The only available countermeasure that can provide immediate immunity against a biological agent is passive antibody. Unlike vaccines, which require time to induce protective immunity and depend on the host's ability to mount an immune response, passive antibody can theoretically confer protection regardless of the immune status of the host. Passive antibody therapy has substantial advantages over antimicrobial agents and other measures for postexposure prophylaxis, including low toxicity and high specific activity. Specific antibodies are active against the major agents of bioterrorism, including anthrax, smallpox, botulinum toxin, tularemia, and plague. This article proposes a biological defense initiative based on developing, producing, and stockpiling specific antibody reagents that can be used to protect the population against biological warfare threats.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Supporting Files:

01-0516_FinalP.nxml	text/plain
license.txt	text/plain

No Related Documents.

You May Also Like:

Biological Weapons Defense: Infectious Diseases and Counterbioterrorism

Personal Author:

Lucey, Daniel R.

Published:

Apr 2006

Source:

Emerg Infect Dis. 12(4):713.

File Type:

[PDF - 52.04 KB]
Potential biological weapons threats.

Personal Author:

Kortepeter, M. G.; Parker, G. W.;

Published:

1999 Jul-Aug

Source:

Emerg Infect Dis. 5(4):523-527.

File Type:

[PDF - 64.92 KB]
Living Weapons: Biological Weapons and International Security

Personal Author:

Cieslak, Theodore J.

Published:

Oct 2010

Source:

Emerg Infect Dis. 16(10):1653.

File Type:

[PDF - 105.49 KB]
Investigating disease outbreaks under a protocol to the biological and toxin weapons convention.

Personal Author:

Wheelis, M.

Published:

2000 Nov-Dec

Source:

Emerg Infect Dis. 6(6):595-600.

Description:

The Biological and Toxin Weapons Convention prohibits the development, production, and stockpiling of biological weapons agents or delivery devices for anything other than peaceful purposes. A protocol currently in the final stages of negotiation add...

File Type:

[PDF - 33.02 KB]
Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains

Personal Author:

Ramos-Sevillano, Elisa; Rodríguez-Sosa, Cinthya; Cafini, Fabio; Giménez, Maria-Jose; Navarro, Ana; Sevillano, David; Alou, Luis; García, Ernesto; Aguilar, Lorenzo; Yuste, Jose;

Published:

Sep 05 2012

Source:

PLoS One. 2012; 7(9).

Description:

Background : Specific antibodies mediate humoral and cellular protection against invading pathogens such as Streptococcus pneumoniae by activating complement mediated immunity, promoting phagocytosis and stimulating bacterial clearance. The emergence...

File Type:

[PDF - 897.77 KB]